PLASMA KINETICS AND PROTEIN-BINDING OF AMSACRINE IN PATIENTS RECEIVING COMBINED CHEMOTHERAPY FOR TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML)

被引：0
|
作者：
JURLINA, JL
VARCOE, R
PAXTON, JW
机构：
[1] UNIV AUCKLAND,SCH MED,DEPT PHARMACOL,AUCKLAND,NEW ZEALAND
[2] AUCKLAND HOSP,DEPT HAEMATOL,AUCKLAND,NEW ZEALAND
来源：
NEW ZEALAND MEDICAL JOURNAL | 1984年 / 97卷 / 752期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：193 / 193
页数：1
相关论文
共 50 条
  • [1] PHARMACOKINETICS OF AMSACRINE IN PATIENTS RECEIVING COMBINED CHEMOTHERAPY FOR TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA
    JURLINA, JL
    VARCOE, AR
    PAXTON, JW
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1985, 14 (01) : 21 - 25
  • [2] MITOXANTRONE AND AMSACRINE - 2 IMPORTANT AGENTS FOR THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML) AND ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL)
    ARLIN, ZA
    BONE MARROW TRANSPLANTATION, 1989, 4 : 57 - 59
  • [3] INFECTION OF ELDERLY PATIENTS RECEIVING HIGH-DOSE CYTARABINE-BASED CHEMOTHERAPY FOR INDUCTION TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA (AML)
    NEMUNAITIS, J
    MEYER, W
    NEMUNAITIS, J
    TAYLOR, E
    RILEY, C
    COOPER, B
    LEUKEMIA RESEARCH, 1994, 18 (08) : 649 - 650
  • [4] Acute myelogenous leukemia (AML) type induction chemotherapy for the patients with myelodysplastic syndrome (MDS)
    Kim, D.-Y.
    Kim, J.-S.
    Kim, B.-S.
    Bang, S.-M.
    Kim, I.
    Yoon, S.-S.
    Park, S.
    Kim, B. K.
    LEUKEMIA RESEARCH, 2007, 31 : S138 - S138
  • [5] PULMONARY INFECTIONS IN PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA RECEIVING AZACITIDINE TREATMENT
    De Angelis, F.
    Latagliata, R.
    De Luca, M. L.
    Carmosino, I.
    Vozella, F.
    Petrucci, L.
    Colafigli, G.
    Mancini, M.
    Morano, S. G.
    Brunetti, G.
    Breccia, M.
    Alimena, G.
    Girmenia, C.
    HAEMATOLOGICA, 2015, 100 : 83 - 84
  • [6] COMBINED CHEMOTHERAPY WITH M-AMSACRINE IN HIGH-RISK PATIENTS WITH ACUTE NONLYMPHOCYTIC LEUKEMIA
    MASCHMEYER, G
    HIDDEMANN, W
    KREUTZMANN, H
    WENDT, F
    ONKOLOGIE, 1987, 10 (01): : 18 - 21
  • [7] RESULTS OF TREATMENT FOR PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA (AML) WHO ARE INELIGIBLE FOR PROTOCOLS
    KEATING, MJ
    ESTEY, E
    KANTARJIAN, H
    OBRIEN, S
    ANDREEFF, M
    FREIREICH, EJ
    BLOOD, 1993, 82 (10) : A541 - A541
  • [8] Treatment with homoharringtonine and cytarabine in patients with high risk acute myelogenous leukemia (AML).
    Chang, Naibai
    Wei, Jianping
    Zhao, Shengming
    Liu, Hui
    Fan, Yun
    Li, Jiangtao
    Xu, Xiaodong
    Gu, Xichun
    BLOOD, 2006, 108 (11) : 218B - 218B
  • [9] INTENSIVE CHEMOTHERAPY IS THE TREATMENT OF CHOICE FOR ELDERLY PATIENTS WITH ACUTE MYELOGENOUS LEUKEMIA
    FOON, KA
    ZIGHELBOIM, J
    YALE, C
    GALE, RP
    BLOOD, 1981, 58 (03) : 467 - 470
  • [10] Decitabine in acute myelogenous Leukemia (AML) Non-intensive but effective Treatment Option for AML Patients
    不详
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (11) : 741 - 741
12345